FTX exchange is contesting a $264 million claim by Jump Trading subsidiary Tai Mo Shan for 800 million Serum (SRM) tokens obtained through a loan agreement with Alameda Research.
The collapse of FTX in 2022 led to the decline of Serum, a decentralized exchange that used SRM as its native cryptocurrency. Jump Trading seeks compensation using an options model considering SRM’s market price, volatility, and other financial factors.
FTX’s legal team argues that Alameda Research failed to fulfill the loan agreement by not delivering the SRM tokens, denying Tai Mo Shan’s claim. FTX disputes the $264 million damages amount, arguing that it has a solid basis and is not clearly defined.
The options model technique used by Jump Trading has been called into question, and suspicions of fraudulent transfers are also raised. The exchange is formulating a liquidation strategy to compensate exchange clients amid ongoing legal disputes.
